Veraxa Biotech AG - Ordinary Shares (NQ:VRXA)Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
52-Week Range
96.1% below 52-week high
1.060
0.9952W Low
27.3652W High
1 Week
7.8% below 1-week high
0.991W Low
1.151W High
Veraxa Biotech AG - Ordinary Shares (VRXA) traded between $0.99 and $27.36 over the past 52 weeks and last traded at $1.06, 96.1% below its 52-week high. Over the past week it ranged between $0.99 and $1.15.
Past 12 Months
1W
-$0.04
1M
-$0.36
3M
-$0.99
6M
-$23.73
YTD
-$23.73
1Y
-$23.73
VRXA was -95.7% over the past year, -95.7% over six months, -95.7% year to date, -3.6% in the last week.
12 Months vs Market
VRXA
DIA
SPY
QQQ
IWM
Over the past 12 months VRXA returned -95.7% versus DIA (Dow) +12.5%, SPY (S&P 500) +15.2%, QQQ (Nasdaq 100) +18.6% and IWM (Russell 2000) +11.9%.
Volume & Liquidity
0.72× 3-mo avg
Today 198,077
3-mo avg 275.6K
1W
1M
3M
6M
YTD
1Y
VRXA most recently traded 198,077 shares against a 3-month average daily volume of 275.6K. More NewsRead More
These stocks are moving in today's session ↗
September 04, 2026
VERAXA Biotech Appoints Raju Willener as Chief Financial Officer
September 04, 2026
Frequently Asked QuestionsIs Veraxa Biotech AG - Ordinary Shares publicly traded?
Yes, Veraxa Biotech AG - Ordinary Shares is publicly traded.
What exchange does Veraxa Biotech AG - Ordinary Shares trade on?
Veraxa Biotech AG - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Veraxa Biotech AG - Ordinary Shares?
The ticker symbol for Veraxa Biotech AG - Ordinary Shares is VRXA on the Nasdaq Stock Market
What is the current price of Veraxa Biotech AG - Ordinary Shares?
The current price of Veraxa Biotech AG - Ordinary Shares is 1.060
When was Veraxa Biotech AG - Ordinary Shares last traded?
The last trade of Veraxa Biotech AG - Ordinary Shares was at 10/21/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
| ||||||||||||||||||||||||
